Physician profile
John Patrick Kozy
NPI 1457857591
$17,865.68
in general payments reported to CMS, 2019-2025
8 companies · $1,189 in 2025
The $1,189 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $769 · 2023: $7,556 · 2024: $8,352 · 2025: $1,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,500 · Grant: $7,500 · Food and Beverage: $1,573 · Travel and Lodging: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,500.00 |
| Grant | $7,500.00 |
| Food and Beverage | $1,572.76 |
| Travel and Lodging | $523.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $15,131.46 | 2023-2024 | Real Intelligence |
| Sportstek Medical, INC | $769.00 | 2019 | |
| Medical Device Business Services, INC. | $587.58 | 2025 | Na |
| Stryker Corporation | $520.58 | 2024-2025 | Mako |
| Depuy Synthes Sales INC. | $472.94 | 2024-2025 | Attune, Na, Actis |
| Medacta USA, INC. | $179.20 | 2024 | |
| Orthalign INC | $149.36 | 2024-2025 | Orthalign Plus |
| Si-Bone, INC. | $55.56 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kozy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.